Validation of the toronto psoriatic arthritis screen version 2 (ToPAS 2)

Journal of Rheumatology

Volumn 42, Issue 5, 2015, Pages 841-846

  Tom, Brian D M ^a   Chandran, Vinod ^b   Farewell, Vernon T ^a   Rosen, Cheryl F ^b   Gladman, Dafna D ^b  

^a Biostatistics Unit UK Institute of Public Health   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Early diagnosis; Psoriasis; Psoriatic arthritis; Screening questionnaire

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; FEMALE; HUMAN; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; PSORIATIC ARTHRITIS; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TORONTO PSORIATIC ARTHRITIS SCREEN; TORONTO PSORIATIC ARTHRITIS SCREEN VERSION 2; AGED; ARTHRITIS, PSORIATIC; MASS SCREENING; METHODOLOGY; VALIDATION STUDY;

ADULT; AGED; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY;

EID: 84940493412     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140857     Document Type: Article

References (10)

1. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, and the CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
2. Gladman DD, Schentag CT, Tom BD, Chandran V, Brockbank J, Rosen CF, et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: The Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2009;68:497-501.
3. Gladman DD. Mortality in psoriatic arthritis. Clin Exp Rheumatol 2008;26 Suppl 5:s62-5.
4. Gladman DD, Thavaneswaran A, Chandran V, Cook RJ. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis 2011;70:2152-4.
5. Haroon M, Gallagher P, Fitzgerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 2014; Feb 27 (E-pub ahead of print).
6. Dominguez P, Gladman DD, Helliwell P, Mease PJ, Husni ME, Qureshi AA. Development of screening tools to identify psoriatic arthritis. Curr Rheumatol Rep 2010;12:295-9.
7. Tinazzi I, Adami S, Zanolin EM, Caimmi C, Confente S, Girolomoni G, et al. The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. Rheumatology 2012;51:2058-63.
8. Coates LC, Aslam T, Al Balushi F, Burden AD, Burden-Teh E, Caperon AR, et al. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol 2013;168:802-7.
9. Walsh JA, Callis DK, Krueger GG, Clegg DO. Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis. J Rheumatol 2013;40:287-93.
10. Haroon M, Kirby B, Fitzgerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis 2013;72:736-40.